Skip to content

Study to Determine the Effect of Trucrose in Patients with Type II Diabetes Mellitus

An Open Label Clinical Study to Evaluate the Effect of Novel Herbal Cane Sugar (Trucrose) in Patients with Type II Diabetes Mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026346
Enrollment
30
Registered
2020-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Trucrose: Subjects will be administered with Trucrose 25 grams of powder orally once daily Control Intervention1: Not Applicable: This is a single arm study hence comparator agent is No

Sponsors

Trulit Herbals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult, both male and female patients with Type 2 DM with fasting blood sugar between 120 and 200mg/dL 2.Those who are not avoiding oral intake of sugar 3.Be geographically accessible for follow up 4.Ability to understand and the willingness to sign and date a written informed consent document at the screening visit before any protocol specific procedures are performed

Exclusion criteria

Exclusion criteria: 1.Preganancy or child bearing ptetntial who are at risk of pregancy 2.Patients with recent stroke or heart attack 3.Fasting blood sugar >200mg/dL 4.Limited life expectancy 5.Patients with rasied Blood Urea and Cretainine or clinical suspicion of Diabetic Neuropathy 6.Recent minor/major surgeries 7.Alcoholic subjects

Design outcomes

Primary

MeasureTime frame
Change in the HbA1C (%) from baseline to end of studyTimepoint: Baseline and End of the Study

Secondary

MeasureTime frame
Change in Serum insulin levels from baseline to end of the studyTimepoint: Baseline and End of the Study;Change in the lipid variables (TC, TG, LDL-C, HDL-C)Timepoint: Baseline and End of the Study;Changes in FPG and 2 hr PPG from baseline to end of the studyhTimepoint: Baseline, Week-2, week-4, week-8 and week-12

Countries

India

Contacts

Public ContactPrathap H D

Trulit Herbals

Trulitherbals@gmail.com9538399009

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026